825 related articles for article (PubMed ID: 17623664)
1. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
[TBL] [Abstract][Full Text] [Related]
2. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
[TBL] [Abstract][Full Text] [Related]
3. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
[TBL] [Abstract][Full Text] [Related]
4. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
5. Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity.
Agrawal A; Parlee S; Perez-Tilve D; Li P; Pan J; Mroz PA; Kruse Hansen AM; Andersen B; Finan B; Kharitonenkov A; DiMarchi RD
Mol Metab; 2018 Jul; 13():45-55. PubMed ID: 29789271
[TBL] [Abstract][Full Text] [Related]
6. Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in
Hansen AMK; Vienberg SG; Lykkegaard K; Zhao X; Tingqing G; Han D; Zhang X; Thøgersen H; Sass-Ørum K; Tagmose T; Raun K; Andersen B
Biochem J; 2018 Sep; 475(18):2985-2996. PubMed ID: 30127091
[TBL] [Abstract][Full Text] [Related]
7. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice.
Wu X; Ge H; Lemon B; Weiszmann J; Gupte J; Hawkins N; Li X; Tang J; Lindberg R; Li Y
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14379-84. PubMed ID: 19706524
[TBL] [Abstract][Full Text] [Related]
9. The Klotho gene family and the endocrine fibroblast growth factors.
Kurosu H; Kuro-o M
Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
[TBL] [Abstract][Full Text] [Related]
10. BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
Ogawa Y; Kurosu H; Yamamoto M; Nandi A; Rosenblatt KP; Goetz R; Eliseenkova AV; Mohammadi M; Kuro-o M
Proc Natl Acad Sci U S A; 2007 May; 104(18):7432-7. PubMed ID: 17452648
[TBL] [Abstract][Full Text] [Related]
11. Fundamentals of FGF19 & FGF21 action in vitro and in vivo.
Adams AC; Coskun T; Rovira AR; Schneider MA; Raches DW; Micanovic R; Bina HA; Dunbar JD; Kharitonenkov A
PLoS One; 2012; 7(5):e38438. PubMed ID: 22675463
[TBL] [Abstract][Full Text] [Related]
12. The structural biology of the FGF19 subfamily.
Beenken A; Mohammadi M
Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
[TBL] [Abstract][Full Text] [Related]
13. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
Kurosu H; Kuro-O M
Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
[TBL] [Abstract][Full Text] [Related]
14. Different roles of N- and C- termini in the functional activity of FGF21.
Micanovic R; Raches DW; Dunbar JD; Driver DA; Bina HA; Dickinson CD; Kharitonenkov A
J Cell Physiol; 2009 May; 219(2):227-34. PubMed ID: 19117008
[TBL] [Abstract][Full Text] [Related]
15. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
17. The Klotho proteins in health and disease.
Kuro-O M
Nat Rev Nephrol; 2019 Jan; 15(1):27-44. PubMed ID: 30455427
[TBL] [Abstract][Full Text] [Related]
18. IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes.
Zhao Y; Meng C; Wang Y; Huang H; Liu W; Zhang JF; Zhao H; Feng B; Leung PS; Xia Y
Am J Physiol Endocrinol Metab; 2016 Feb; 310(4):E289-300. PubMed ID: 26670488
[TBL] [Abstract][Full Text] [Related]
19. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action.
Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y
EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926
[TBL] [Abstract][Full Text] [Related]
20. Co-receptor requirements for fibroblast growth factor-19 signaling.
Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]